与帕金森病相关的V15A突变通过减少膜亲和力来促进α-synuclein聚合
Fiamma A Buratti1,2, Claudio Oscar Fernández2,3, Markus Zweckstetter1,3
1German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
Protein science : a publication of the Protein Society
|June 26, 2023
概括
阿尔法-同核素V15A突变减弱了膜结合,促进了帕金森病中粉样纤维的形成. 这表明需要在自由和膜结合的α-synuclein之间取得关键平衡,以预防疾病.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 帕金森病 (PD) 偶尔出现或作为遗传的自体主导特征.
- 在α-synuclein (α-synuclein) 中错误的突变与遗传形式的PD有关.
- 最近在PD家庭中发现了V15Aα-synuclein变体.
研究的目的:
- 研究V15Aα-synuclein突变对蛋白质构成,膜亲和和聚合的影响.
- 了解V15A突变对帕金森病的病原发生有所贡献的分子机制.
主要方法:
- 核磁共振 (NMR) 光谱法用于分析蛋白质构成.
- 膜结合试验用于量化α-synuclein-lipid相互作用.
- 聚合试验用于观察粉样纤维素在脂质体存在时的形成.
主要成果:
- V15A突变对溶液中的单体α-synuclein的构造组合的影响很小.
- V15A显著削弱了α-synuclein对脂质膜的亲和力.
- 薄弱的膜结合增加了自由的,聚合能力强的α-synuclein,促进了V15A特异性粉样蛋白纤维与脂质体的形成.
结论:
- V15A突变通过改变其膜相互作用来促进α-synuclein聚合.
- 保持膜结合和自由聚合能力的α-synuclein之间的平衡对于预防α-synucleinopathies至关重要.
- 这些发现提供了对帕金森病中α-synuclein误解突变的致病机制的见解.
更多相关视频
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.8K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
相关概念视频
Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
